6533b82dfe1ef96bd12908b3
RESEARCH PRODUCT
EGFR mutant cfDNA and CTC detection as biomarkers in patients diagnosed with advanced non-small cell lung cancer.
Miguel Angel Molina-vilaNúria Jordana-arizaCarlos CampsEloisa Jantus-lewintreRafael RosellClara Mayo De Las CasasAriadna BaladaSilvia Calabuig-fariñasAna Blascosubject
Cancer Researchbusiness.industryMutantCancermedicine.diseaseOncologyCancer researchMedicineBiomarker (medicine)In patientNon small cellLiquid biopsybusinessLung cancerdescription
e23039Background: One of the most promising developments in translational cancer has been the emergence of liquid biopsy as a non-invasive biomarker. CTCs and cfDNA offer valuable prognostic and pr...
year | journal | country | edition | language |
---|---|---|---|---|
2016-05-20 | Journal of Clinical Oncology |